Search Results

Data demonstrates improvement in cardiac function and reductions in cardiac hypertrophy, remodeling, inflammation, and cell death - key underlying mechanisms in heart failure

CND Life Sciences (CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests and associated biomarker services, today announced a pivotal peer-reviewed publication entitled, “Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients with Synucleinopathies”1 in the Journal of the American Medical Association (JAMA).

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Diabetes Care, the peer-reviewed journal of the American Diabetes Association, has published a research paper on the company’s Phase 2 RELIEF-DPN-1 clinical trial investigating LX9211 for the treatment of diabetic peripheral neuropathic pain (DPNP).

Adeno-associated Virus Gene Therapy Market Outlook 2025-2035:

Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE) today announced the publication of the manuscript titled “Hydronidone induces apoptosis in activated hepatic stellate cells through endoplasmic reticulum stress-associated mitochondrial apoptotic pathway” in the Journal of Gastroenterology and Hepatology.

Cardio Diagnostics Holdings, Inc., a leader in artificial intelligence-driven precision cardiovascular medicine tests, announced the publication of its groundbreaking study in the Journal of the American Heart Association, an official journal of the American Heart Association.